Conformis, Inc. (CFMS): Price and Financial Metrics
CFMS Price/Volume Stats
Current price | $2.26 | 52-week high | $7.25 |
Prev. close | $2.26 | 52-week low | $1.05 |
Day low | $2.25 | Volume | 7,000 |
Day high | $2.27 | Avg. volume | 99,585 |
50-day MA | $2.23 | Dividend yield | N/A |
200-day MA | $2.06 | Market Cap | 17.80M |
CFMS Stock Price Chart Interactive Chart >
Conformis, Inc. (CFMS) Company Bio
ConforMIS is a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants that are individually sized and shaped, or customized, to fit each patient's unique anatomy. The company was founded in 2004 and is based in Bedford, Massachusetts.
Latest CFMS News From Around the Web
Below are the latest news stories about CONFORMIS INC that investors may wish to consider to help them evaluate CFMS as an investment opportunity.
restor3d Completes Acquisition of ConformisCombination Creates the World’s Preeminent Producer of Personalized Orthopedic Medical Devices, with Unmatched Additive Manufacturing CapabilitiesDURHAM, North Carolina and BILLERICA, Mass., Sept. 05, 2023 (GLOBE NEWSWIRE) -- restor3d, Inc. and Conformis, Inc. announced today that restor3d has completed its previously announced acquisition of Conformis following the approval of Conformis’ stockholders at a special meeting held on August 31, 2023. In connection with the completion of the acquisit |
Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Conformis Stockholders Vote “FOR” the Pending Merger with restor3dBILLERICA, Mass., Aug. 23, 2023 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), a leading medical technology company featuring personalized knee and hip replacement products, announced today that leading independent proxy advisory firms, Institutional Shareholder Services Inc. (“ISS”) and Glass Lewis & Co., LLC (“Glass Lewis”), have each recommended that Conformis stockholders vote “FOR” the pending merger transaction with restor3d. As previously announced, under the terms of the definitive m |
Independent Proxy Advisory Firm ISS Recommends Conformis Stockholders Vote “FOR” the Pending Merger with restor3dBILLERICA, Mass., Aug. 21, 2023 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), a leading medical technology company featuring personalized knee and hip replacement products, announced today that leading independent proxy advisory firm, Institutional Shareholder Services Inc. (“ISS”), has recommended that Conformis stockholders vote “FOR” the pending merger transaction with restor3d. As previously announced, under the terms of the definitive merger agreement, restor3d will acquire all outstan |
ConforMIS (CFMS) Reports Q2 Loss, Tops Revenue EstimatesConforMIS (CFMS) delivered earnings and revenue surprises of -34.85% and 2.71%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock? |
Conformis Reports Second Quarter 2023 Financial ResultsBILLERICA, Mass., Aug. 02, 2023 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), an orthopedic medical device company that features personalized knee and hip replacement products, announced today financial results for the second quarter ended June 30, 2023. Second Quarter 2023 Summary Total revenue of $13.0 million, a decrease of 15% year-over-year on a reported and constant currency basis.Product revenue of $12.5 million, a decrease of 17% year-over-year on a reported and constant currency ba |
CFMS Price Returns
1-mo | N/A |
3-mo | N/A |
6-mo | N/A |
1-year | 56.94% |
3-year | -90.49% |
5-year | -96.48% |
YTD | N/A |
2023 | 0.00% |
2022 | -82.56% |
2021 | 15.36% |
2020 | -56.00% |
2019 | 316.67% |
Continue Researching CFMS
Here are a few links from around the web to help you further your research on Conformis Inc's stock as an investment opportunity:Conformis Inc (CFMS) Stock Price | Nasdaq
Conformis Inc (CFMS) Stock Quote, History and News - Yahoo Finance
Conformis Inc (CFMS) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...